The impact of the new who Antiretroviral treatment guidelines on HIV epidemic dynamics and cost in south africa

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Hontelez, Jan A C ^a,b,c   de Vlas, Sake J ^a   Tanser, Frank ^b   Bakker, Roel ^a   Bärnighausen, Till ^b,d   Newell, Marie Louise ^b   Baltussen, Rob ^c   Lurie, Mark N ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EPIDEMIC; HEALTH CARE COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION CONTROL; LIFE TABLE; MORTALITY; PRACTICE GUIDELINE; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SEXUALITY; SOUTH AFRICA; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; DISEASE TRANSMISSION; ECONOMICS; FEMALE; IMMUNOLOGY; MALE; PREGNANCY; STATISTICS; THEORETICAL MODEL; TIME;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; EPIDEMICS; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SOUTH AFRICA; TIME FACTORS; WORLD HEALTH ORGANIZATION;

EID: 79960604515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021919     Document Type: Article

References (48)

1. WHO (2009) Rapid Advice: Antiretroviral therapy for HIV infected adults and adolescents. Geneva: World Health Organization. Available: www.who.int/hiv/pub/arv/rapid_advice_art.pdf Accessed 2011 Jan 30.
2. SANAC (2010) The South African antiretroviral treatment guidelines 2010. Pretoria: South African National AIDS Council. Available: http://www.sanac.org.za/resources/art-guidelines. Accessed 2010 Dec 20.
3. SANAC (2010) Media statement: outline of the national HIV counseling and testing (HTC) campaign. Available: http://www.sanac.org.za/documents/Media%20Statement%2025%2003%2010.pdf. Accessed 2010 Apr 30.
4. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Furher J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med 338: 853-860.
5. Sterne JA, May M, Costagliola D, de Wolf F, Philips AN, et al. (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352-1363.
6. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, et al. (2009) When to start antiretroviral therapy in resource-limited settings. Ann Intern Med 151: 157-166.
7. Attia S, Egger M, Muller M, Zwahlen M, Low N, (2009) Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23: 1397-1404.
8. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153.
9. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Eng J Med 342: 921-929.
10. Harling G, Wood R, (2007) The evolving cost of HIV in South Africa: changes in health care cost with duration on antiretroviral therapy for public sector patients. J Acquir Immune Defic Syndr 45: 348-354.
11. Leisegang R, Cleary S, Hislop M, Davidse A, Regensberg L, et al. (2009) Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis. PLoS Med 6: e1000189.
12. UNAIDS (2008) Epidemiological fact sheet on HIV and AIDS South Africa. Geneva: UNAIDS Available: http://www.unaids.org/en/CountryResponses/Countries/south_africa.asp. Accessed 2010 Apr 20.
13. Bärnighausen T, Tanser F, Gqwede Z, Mbizana C, Herbst K, et al. (2008) High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study. AIDS 22: 139-144.
14. Bärnighausen T, Tanser F, Newell ML, (2009) Lack of a decline in HIV incidence in a rural community with high HIV prevalence in South Africa, 2003-2007. AIDS Res Hum Retroviruses 25: 405-409.
15. Tanser F, Hosegood V, Bärnighausen T, Herbst K, Nyirenda M, et al. (2009) Cohort Profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 37: 956-962.
16. Houlihan CF, Bland R, Mutevedzi P, Lessels RJ, Ndirangu J, et al. (2010) Cohort Profile: Hlabisa HIV treatment and care programme. Int J Epidemiol 40: 318-326.
17. Mutevedzi P, Lessells RJ, Heller T, Bärnighausen T, Cooke GS, et al. (2010) Scale-up of a decentralised HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ 88: 593-600.
18. Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, et al. (2009) Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 87: 754-762.
19. van der Ploeg CPB, Van Vliet C, De Vlas SJ, Ndinya-Achola JO, Fransen L, et al. (1998) STDSIM: A microsimulation model for decision support in STD control. Interfaces 28: 84-100.
20. Orroth KK, Freeman EE, Bakker R, Buve A, Glynn JR, et al. (2007) Understanding the differences between contrasting HIV epidemics in east and West Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect 83 (Suppl 1): i5-16.
21. Dodd PJ, Garnett GP, Hallett TB, (2010) Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 24: 729-735.
22. Donnell D, Baeten J, Kiarie J, Thomas K, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
23. Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, et al. (2006) Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Med 3: e4.
24. Médecins SansFrontières (2010) Untangling the web of ARV price reductions. Available: http://www.msfaccess.org/main/hiv-aids/untangling-the-web/. Accessed 2010 Dec 10.
25. Statistics South Africa (2010) historical PPI key indicators. Available: http://www.statssa.gov.za/keyindicators/CPI/CPIHistory.pdf. Accessed 2010 Apr 30.
26. US Federal ReserveBoard (2010) Foreign exchange rates. South Africa historical rates (annual) 2010. Available: http://www.federalreserve.gov/releases/H10/hist/dat00_sf.htm. Accessed 2010 Apr 30.
27. WHO (2003) Making choices in health: WHO guide to cost-effectiveness analysis. Geneva:World Health Organization.
28. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
29. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM, (2008) Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 372: 314-320.
30. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem, et al. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS 24: 2263-2270.
31. Muhwava W, Nyirenda M, (2007) Demographic and socio-economic trends in the ACDIS, monograph No 2. Mtubatuba, South Africa: Africa Centre for Health and Population Studies. Available: http://www.africacentre.ac.za/Default.aspx?tabid=105. Accessed 2010 Apr 30.
32. Todd J, Cremin I, McGrath N, Bwanika JB, Wringe A, et al. (2009) Reported number of sexual partners: comparison of data from four African longitudinal studies. Sex Transm Infect 85 Suppl 85 (Suppl): i72-80.
33. White RG, Moodley P, McGrath N, Hosegood V, Zaba B, et al. (2008) Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect 84: 528-534.
34. Weinhardt LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE, (1998) Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav 27: 155-80.
35. Carael M, Cleland J, Adeokun L, (1991) Overview and selected findings of sexual behaviour surveys. AIDS 5 (Suppl 1): S65-74.
36. Nnko S, Boerma JT, Urassa M, Mwaluko G, Zaba B, (2004) Secretive females or swaggering males? An assessment of the quality of sexual partnership reporting in rural Tanzania. Soc Sci Med 59: 299-310.
37. Lees S, Cook C, Vallely A, Desmond N, Allen C, et al. (2010) Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania. Sex Transm Dis 37: 497-501.
38. Ndirangu J, Newell ML, Tanser F, Herbst AJ, Bland R, (2010) Decline in early life mortality in a high HIV prevalence rural area of South Africa: evidence of HIV prevention or treatment impact? AIDS 24: 593-602.
39. Waning B, Kaplan W, King AC, Lawrence DA, Leufkens HG, et al. (2009) Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. Bull World Health Organ 87: 520-528.
40. Crepaz N, Hart TA, Marks G, (2004) Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 292: 224-236.
41. Kennedy C, O'Reilly K, Medley A, Sweat M, (2007) The impact of HIV treatment on risk behaviour in developing countries: a systematic review. AIDS Care 19: 707-720.
42. Blower S, Bodine E, Kahn J, McFarland W, (2005) The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS 19: 1-14.
43. WHO, (2009) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization. Available: http://www.who.int/hiv/mediacentre/universal_access_progress_report_en.pdf. Accessed 2010 Apr 30.
44. Bartlett JA, Shao JF, (2009) Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis 9: 637-49.
45. Callaghan M, Ford N, Schneider H, (2010) A systematic review of task shifting for HIV treatment and care in Africa. Hum Resour Health 8: 8.
46. Abbas UL, Anderson RM, Mellors JW, (2006) Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr 41: 632-41.
47. Baggaley RF, Ferguson NM, Garnett GP, (2005) The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol 2: 9.
48. Baggaley RF, Garnett GP, Ferguson NM, (2006) Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 3: e124.